Protalix BioTherapeutics
PLX
PLX
66 hedge funds and large institutions have $17.9M invested in Protalix BioTherapeutics in 2023 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 7 closing their positions.
Holders
66
Holders Change
+32
Holders Change %
+94.12%
% of All Funds
1.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
39
Increased
15
Reduced
6
Closed
7
Calls
$2.82M
Puts
$838K
Net Calls
+$1.98M
Net Calls Change
-$1.18M
Top Buyers
1 |
1
BlackRock
New York
|
$5.28M |
2 |
2
State Street
Boston,
Massachusetts
|
$1.46M |
3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$1.1M |
4 |
![]()
4
Marshall Wace
London,
United Kingdom
|
$1.12M |
5 |
5
Northern Trust
Chicago,
Illinois
|
$726K |